CIBMTR® Launches Rapid Clinical Site Selection and Activation, Resulting in Faster Trial Enrollment for Cell and Gene Therapy Trials
May 01 2024 - 10:00AM
Business Wire
Leveraging Master Contracts with Clinical
Centers of Excellence, CIBMTR Launches a Dedicated Site Startup
Team. Expert Physician Insight Leads to Fewer Obstacles Navigating
IRB, DSMB and Regulatory Review
The CIBMTR CRO Services team will be
presenting at the Association of Clinical Research Professionals
(ACRP) 2024 Annual Meeting in Anaheim, May 3–7
NMDP BioTherapies announced today that CIBMTR CRO Services now
offers a rapid clinical site selection and activation service,
resulting in faster trial enrollment for cell and gene therapy
(CGT) trials. By leveraging data from its 675,000+ patient clinical
outcomes database, CIBMTR can quickly identify, vet and select
transplant centers based on patient population, diversity and
competing trials.
“At hand-off to our dedicated site startup team, we leverage our
deep relationships with transplant centers to get your CGT trial
activated and enrolling quickly, which enables sponsors to reduce
the time required to launch and execute high-impact clinical
trials,” notes Erin Leckrone, Vice President, Clinical Trials. “In
addition, expert CIBMTR physician review enables endpoint
efficiencies and mitigates barriers, allowing a refined protocol to
progress more quickly through IRB, DSMB and regulatory body
approvals.”
CIBMTR CRO Services’ team of clinical trial experts will be
sharing their insights, experiences and strategies aimed at
accelerating trial implementation and execution through two
presentations, (i) fostering a clinical research associate (CRA)
culture of excellence and (ii) critical data oversight structures
at the upcoming Association of Clinical Research Professionals
(ACRP) 2024 Annual Meeting.
Here's a glimpse of what attendees can expect:
- Title: A CRO Training
Program for Overcoming Workforce Development Roadblocks
Presenters: Kathleen Kane,
Alisha Mussetter, Kassandra Nealon Date
& Time: Monday, May 6, 2024, 10:30-11:30 a.m. PT
Content: This session offers
actionable strategies for enhancing clinical research training
programs, drawing from the success of a CRA training program
implemented by a small contract research organization. Attendees
will learn how to foster a culture of excellence and growth within
their teams.
- Title: Understanding Roles
& Responsibilities in a World of Increasing Data Complexity
Presenter: Kathleen Kane
Date & Time: Sunday, May 5,
2024, 10:15-11:15 a.m. PT Content: In an era marked by increasing data
complexity, this session explores foundational data oversight
concepts crucial for successful clinical investigations. Kathleen
will discuss the importance of clearly defining roles and
responsibilities across multidisciplinary stakeholders.
CIBMTR CRO Services are a collaborative effort between NMDP
BioTherapies and the CIBMTR, resulting in unique expertise and
access to unparalleled resources, including research, sites,
donors, partnerships and scientific and operational expertise.
About NMDP BioTherapies
NMDP BioTherapies is the only cell and gene therapy solutions
provider with customizable services to support the end-to-end cell
therapy supply chain. Backed by the industry-leading experience of
NMDP℠ and a research partnership with the CIBMTR® (Center for
International Blood and Marrow Transplant Research®), the
organization designs solutions that advance the development of cell
and gene therapies across the globe.
NMDP BioTherapies is dedicated to accelerating patient access to
life-saving cell and gene therapies by providing high-quality
cellular source material from the NMDP Registry℠, the world’s most
diverse registry of more than 7 million potential blood stem cell
donors. Through established relationships with apheresis, marrow
collection, and transplant centers worldwide, the organization
develops, onboards, trains, and manages expansive collection
networks to advance cell therapies. NMDP BioTherapies uses a proven
infrastructure consisting of regulatory compliance and managed
logistics experts and cell therapy supply chain case managers to
successfully transport and deliver regulatory-compliant life-saving
therapies across the globe. Through the CIBMTR, NMDP BioTherapies
extends services beyond the cell therapy supply chain to include
long-term follow-up tracking for FDA-approved CAR-T therapies.
For more information, follow NMDP BioTherapies on LinkedIn or
Twitter.
About the CIBMTR
The CIBMTR® (Center for International Blood and Marrow
Transplant Research®) is a research collaboration between NMDP℠ and
the Medical College of Wisconsin (MCW). The CIBMTR collaborates
with the global scientific community to advance hematopoietic cell
transplantation (HCT) and cellular therapy worldwide to increase
survival and enrich quality of life for patients. The CIBMTR
facilitates critical observational and interventional research
through scientific and statistical expertise, a network of more
than 300 transplant centers, and one of the largest databases
worldwide for clinical outcomes of cellular therapy, and a
biorepository with tissue samples.
For more information on the CIBMTR, please visit www.cibmtr.org
or follow the CIBMTR on Facebook, LinkedIn, or Twitter.
About the Medical College of Wisconsin
The Medical College of Wisconsin brings together the most
inquisitive minds in science, medicine, education and community
engagement to solve the toughest challenges in health and society
today. Academic medicine is at the core, where scientists,
physicians and students work together with the community to ask the
questions no one else is and fuel the continuous cycle of knowledge
that’s shaping the future or medicine.
For more information, visit www.mcw.edu or follow the Medical
College of Wisconsin on Facebook, LinkedIn, and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240501144724/en/
Matt Mayr Info@NMDPbiotherapies.com (800) 471-4431